TuHURA Biosciences Inc (NASDAQ: HURA)’s stock price has soared by 23.11 in relation to previous closing price of 4.17. Nevertheless, the company has seen a gain of 24.90% in its stock price over the last five trading days. globenewswire.com reported 2024-12-20 that NEW YORK, Dec. 20, 2024 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Is It Worth Investing in TuHURA Biosciences Inc (NASDAQ: HURA) Right Now?
The 36-month beta value for HURA is at 0.90. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for HURA is 23.89M, and currently, shorts hold a 2.93% of that float. The average trading volume for HURA on January 10, 2025 was 287.77K shares.
HURA’s Market Performance
The stock of TuHURA Biosciences Inc (HURA) has seen a 24.90% increase in the past week, with a -13.43% drop in the past month, and a -21.10% fall in the past quarter. The volatility ratio for the week is 13.31%, and the volatility levels for the past 30 days are at 13.73% for HURA. The simple moving average for the past 20 days is 14.51% for HURA’s stock, with a -17.54% simple moving average for the past 200 days.
Analysts’ Opinion of HURA
Many brokerage firms have already submitted their reports for HURA stocks, with Rodman & Renshaw repeating the rating for HURA by listing it as a “Buy.” The predicted price for HURA in the upcoming period, according to Rodman & Renshaw is $11 based on the research report published on December 19, 2024 of the previous year 2024.
Maxim Group, on the other hand, stated in their research note that they expect to see HURA reach a price target of $15. The rating they have provided for HURA stocks is “Buy” according to the report published on November 05th, 2024.
HURA Trading at 6.77% from the 50-Day Moving Average
After a stumble in the market that brought HURA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -64.83% of loss for the given period.
Volatility was left at 13.73%, however, over the last 30 days, the volatility rate increased by 13.31%, as shares sank -19.06% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -8.40% lower at present.
During the last 5 trading sessions, HURA rose by +16.79%, which changed the moving average for the period of 200-days by +53.92% in comparison to the 20-day moving average, which settled at $4.47. In addition, TuHURA Biosciences Inc saw 25.51% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for HURA
The total capital return value is set at -4.16. Equity return is now at value -370.77, with -163.44 for asset returns.
Currently, EBITDA for the company is -29.12 million with net debt to EBITDA at 0.39. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.45.
Conclusion
In conclusion, TuHURA Biosciences Inc (HURA) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
